CERo Therapeutics (NASDAQ:CERO) Shares Up 4.6% – Here’s What Happened

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) traded up 4.6% during mid-day trading on Monday . The stock traded as high as $1.03 and last traded at $0.95. 435,535 shares were traded during mid-day trading, an increase of 17% from the average session volume of 373,681 shares. The stock had previously closed at $0.91.

CERo Therapeutics Stock Up 4.6 %

The business has a 50 day moving average price of $1.75 and a 200-day moving average price of $7.48.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in CERo Therapeutics stock. Avantax Planning Partners Inc. boosted its stake in shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) by 89.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,585,151 shares of the company’s stock after purchasing an additional 1,224,021 shares during the quarter. Avantax Planning Partners Inc. owned approximately 172.00% of CERo Therapeutics worth $155,000 at the end of the most recent reporting period. 29.64% of the stock is owned by institutional investors and hedge funds.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.